SCHEMBL7832235

SCHEMBL7832235

CS(=O)(=O)c1ccc(-c2sc(NC(=O)c3cccc(Br)c3)nc2-c2ccc(F)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 17/20 0.53
PTGS1 P23219 2/20 0.52
MAPT P10636 2/20 0.48
USP2 O75604 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7839831 1.00 PTGS2 (0.53) PTGS2PTGS1MAPTUSP2L3MBTL1
SCHEMBL7843314 0.91 PTGS2 (0.55) PTGS2PTGS1MAPTUSP2L3MBTL1
SCHEMBL7842695 0.91 PTGS2 (0.55) PTGS2PTGS1MAPTUSP2L3MBTL1
SCHEMBL7843582 0.91 PTGS2 (0.49) PTGS2PTGS1MAPTUSP2LMNA
SCHEMBL7845250 0.91 PTGS2 (0.49) PTGS2PTGS1MAPTUSP2LMNA
SCHEMBL7842692 0.89 KMT2A (0.60) PTGS2PTGS1MAPTUSP2L3MBTL1
SCHEMBL7842452 0.89 KMT2A (0.60) PTGS2PTGS1MAPTUSP2L3MBTL1
SCHEMBL7841748 0.88 PTGS2 (0.56) PTGS2PTGS1MAPTUSP2L3MBTL1
SCHEMBL7844500 0.88 PTGS2 (0.56) PTGS2PTGS1MAPTUSP2L3MBTL1
SCHEMBL7846124 0.88 PTGS2 (0.62) PTGS2PTGS1MAPTUSP2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1125932-A2 Substituted thiazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-22 EP disclosed
US-5668161-A Substituted thiazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 1997-09-16 US disclosed
EP-0772606-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003392-A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed